Governments around the globe are preparing to rebuild economies following the impact of Covid-19. In the UK, the PM announced the Build Build Build project which is set to inject...
There is widespread agreement across the pharmaceutical industry that the vast majority of trials fail to meet their timeline targets. This article makes the case that a significant part of...
In an increasingly competitive and cost-sensitive environment, CROs need to be better informed on how risky a particular bid price might be (the probability of making a profit or loss)....